Gastroenterologists cited a range of challenges treating IBS in KMK’s recent Innovation & Customer Value Survey. Topping the list were the high cost of medication and patient education and understanding of the disease.

Concurrently, the study found that support services offered by pharmaceutical companies to lower costs and offer access were most commonly utilized to aid gastroenterologists in treating IBS. To see the full list of challenges and support services, view the summary below or download the PDF.

To learn more about the study, view the press release, or contact us to discuss the survey results in detail: James Charnetski, james.charnetski@kmkconsultinginc.com; Gregory Chu, greg.chu@kmkconsultinginc.com